• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs
    1. Home
    2. Stocks
    3. Vivanza Share Price

    Vivanza Biosciences Share PriceVivanza Biosciences

    Small Cap 1.8k Result
    ₹8.55
    -0.44 (-4.89%)
    As on 09 December, 2023 | 08:16 BSE: 530057 NSE: VIVANZAISIN: INE984E01035
    Split

    Vivanza Biosciences Performance

    Day Range

    • Low
    • High
    ₹ 8.55

    52 Week Range

    • Low
    • High
    ₹ 8.55
    • Open Price
    • Previous Close
    • Volume

    Start SIP in Vivanza Biosciences

    Start SIP

    Vivanza Biosciences Share Price

    • Over 1 Month -28.15%
    • Over 3 Month -35.96%
    • Over 6 Month -31.65%
    • Over 1 Year -39.49%

    Vivanza Biosciences Key Statistics

    Vivanza Biosciences Investment Rating

    • Master Rating:

    • Vivanza Biosciences has an operating revenue of Rs. 30.95 Cr. on a trailing 12-month basis. An annual revenue growth of 63% is outstanding, Pre-tax margin of 4% needs improvement, ROE of 14% is good. The company has a reasonable debt to equity of 35%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 97 which is a GREAT score indicating consistency in earnings, a RS Rating of 1 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 74 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail. Please note that this is a thinly traded stock.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Vivanza Biosciences Financials
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 4565126
    Operating Expenses Qtr Cr 4464126
    Operating Profit Qtr Cr 0001000
    Depreciation Qtr Cr 0000000
    Interest Qtr Cr 0000000
    Tax Qtr Cr 0000000
    Net Profit Qtr Cr 0000000
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 1510
    Operating Expenses Annual Cr 139
    Operating Profit Annual in Cr 10
    Depreciation Cr 00
    Interest Annual Cr 00
    Tax Annual Cr 00
    Net Profit Annual Cr 10
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr 0-1
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr 01
    Net Cash Flow Annual Cr 00
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 44
    Fixed Assets Annual Cr 00
    Total Non Current Assets Annual Cr 33
    Total Current Assets Annual Cr 189
    Total Assets Annual Cr 2011
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 110
    ROE Annual % 1312
    ROCE Annual % 2523
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 810
    IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 8986126
    Operating Expenses Qtr Cr 7985126
    Operating Profit Qtr Cr 0101000
    Depreciation Qtr Cr 0000000
    Interest Qtr Cr 0000000
    Tax Qtr Cr 0000000
    Net Profit Qtr Cr 0000000
    IndicatorMar 2023Mar 2022
    Total Revenue Annual Cr 1811
    Operating Expenses Annual Cr 1710
    Operating Profit Annual in Cr 10
    Depreciation Cr 00
    Interest Annual Cr 00
    Tax Annual Cr 00
    Net Profit Annual Cr 10
    IndicatorMar 2023Mar 2022
    Cash from Operating Activity Annual Cr -1
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr 1
    Net Cash Flow Annual Cr 0
    IndicatorMar 2023Mar 2022
    Total ShareHolders Funds Annual Cr 43
    Fixed Assets Annual Cr 11
    Total Non Current Assets Annual Cr 33
    Total Current Assets Annual Cr 2010
    Total Assets Annual Cr 2213
    IndicatorMar 2023Mar 2022
    Book Value Per Share Annual Rs 19
    ROE Annual % 1510
    ROCE Annual % 2112
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 67
    Invest in Vivanza Biosciences

    Vivanza Biosciences Technicals

    EMA & SMA

    Current Price
    ₹8.55
    -0.44 (-4.89%)
    pointer
    • Bullish Moving Average
    • ___
    • 0
    • Bearish Moving Average
    • ___
    • 16
    • 20 Day
    • ₹9.06
    • 50 Day
    • ₹10.08
    • 100 Day
    • ₹11.06
    • 200 Day
    • ₹11.97
    • 20 Day
    • ₹8.67
    • 50 Day
    • ₹10.34
    • 100 Day
    • ₹11.48
    • 200 Day
    • ₹12.72

    Vivanza Biosciences Resistance and Support

    PIVOT
    ₹8.87
    Resistance
    First Resistance 9.18
    Second Resistance 9.68
    Third Resistance 10.00
    RSI 41.40
    MFI 50.80
    MACD Single Line -0.70
    MACD -0.53
    Support
    First Resistance 8.36
    Second Resistance 8.04
    Third Resistance 7.54

    Vivanza Biosciences Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 11,323 1,132,300 100
    Week 26,580 2,658,040 100
    1 Month 52,084 4,947,971 95
    6 Month 21,384 2,084,262 97.47

    Vivanza Biosciences Result Highlights

    Vivanza Biosciences Synopsis

    BSE-Medical-Diversified

    Vivanza Biosciences is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 14.21 Cr. and Equity Capital is Rs. 4.00 Cr. for the Year ended 31/03/2023. Vivanza Biosciences Ltd. is a Public Limited Listed company incorporated on 06/03/1982 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24110GJ1982PLC005057 and registration number is 005057.
    Market Cap 34
    Sales 20
    Shares in Float 0.21
    No of funds 2
    Yield
    Book Value 7.77
    U/D Vol ratio
    LTDebt / Equity
    Alpha 0.85
    Beta -0.62

    Vivanza Biosciences

    Owner NameSep-23Jun-23Mar-23Dec-22
    Promoters 47.29%47.8%47.8%47.8%
    Financial Institutions/ Banks
    Individual Investors 6.23%5.66%5.65%5.67%
    Others 46.48%46.54%46.55%46.53%

    Vivanza Biosciences Management

    Name Designation
    Mr. Mehta J A Managing Director
    Ms. A S Vyas Independent Woman Director
    Mr. Parikh H A Director
    Mr. Shah S D Independent Director

    Vivanza Biosciences Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Vivanza Biosciences Corporate Action

    Date Purpose Remarks
    2023-10-26 Quarterly Results
    2023-08-10 Quarterly Results
    2023-06-30 A.G.M. Inter alia, to consider and approve the Directors Report and Secretarial Audit Report along with annexure for the Financial Year 2022-23. split from Rs. 10/- to Re. 1/-.
    2023-04-25 Audited Results
    2023-03-04 Stock Split
    Date Purpose Remarks
    2023-03-24 Split Rs.0.00 split from Rs. 10/- to Re. 1/-.

    Vivanza Biosciences FAQs

    What is Share Price of Vivanza Biosciences ?

    Vivanza Biosciences share price is ₹8 As on 09 December, 2023 | 08:02

    What is the Market Cap of Vivanza Biosciences ?

    The Market Cap of Vivanza Biosciences is ₹34.2 Cr As on 09 December, 2023 | 08:02

    What is the P/E ratio of Vivanza Biosciences ?

    The P/E ratio of Vivanza Biosciences is 30.8 As on 09 December, 2023 | 08:02

    What is the PB ratio of Vivanza Biosciences ?

    The PB ratio of Vivanza Biosciences is 8.4 As on 09 December, 2023 | 08:02

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.